Events

New Horizons In ES-SCLC

A meeting proudly sponsored by Amgen, focusing on current treatments and future therapies for Extensive Stage Small Cell Lung Cancer (ES-SCLC).
Monday, August 12, 2024
6:30 pm
– 8:00 pm AEST

A meeting proudly sponsored by Amgen, with a theme focusing on current treatments and future therapies for Extensive Stage Small Cell Lung Cancer (ES-SCLC), chaired by A/Prof Surein Arulananda and co-chaired by Prof Nick Pavlakis.

Chairs

A/Prof

Surein Arulananda

MBBS BMedSci PhD FRACP

Deputy Director, Medical Oncology, Monash Health and TOGA SCLC/Mesothelioma Co-Chair

Speakers

Prof

Kate Sutherland

BSc PhD

Laboratory Head, The Walter and Eliza Hall Institute of Medical Research and TOGA Scientific Committee Translational Research Co-Chair

Prof

Michael Boyer

MBBS, FRACP

Chief Executive Officer at Chris O'Brien Lifehouse

Prof

Nick Pavlakis

BSc MBBS MMEd (Clin Epi) PhD FRACP

Medical Oncologist, Royal North Shore Hospital / Chair, TOGA Board of Directors

Dr

Rebecca Tay

MBBS (Hons), FRACP

Medical Oncologist, Royal Hobart Hospital / Icon Cancer Centre and TOGA Scientific Committee SCLC/Mesothelioma Co-Chair

Dr

Sagun Parakh

BSc MBChB FRACP PhD

Medical Oncologist and Clinician Scientist, Austin Hospital

Thank you to our Sponsor

Event Recording

Play Video